NewsLiquid Biopsies Offer Quicker, Easier Lung Cancer TestingPat Carragher, Endeavor, Moffitt Cancer Center | January8th,2021 A new liquid biopsy test uses next-generation sequencing to identify specific mutations in NSCLC
Thought LeadershipSponsoredThe Key to Increased Sensitivity in Liquid BiopsyErica Tennenhouse, PhD | October27th,2020 Higher conversion increases data quality and accuracy of results
Thought LeadershipSponsoredThe Power of Predictive BiomarkersGeorge Karlin-Neumann, PhD | July21st,2020 ddPCR-based liquid biopsies can provide reliable and timely biomarker information to help guide treatment decisions
InsightThe Need for Standardization in Liquid Biopsy Sample PrepCatherine Crawford-Brown | June4th,2020 Reproducible workflows would help clinical labs successfully and routinely perform liquid biopsy assays
InfographicsMicrofluidic Technology for Cancer DiagnosisClinical Lab Manager | June1st,2020 Exploring some of the microfluidic technologies used for cancer diagnosis
NewsBlood Test May Help Doctors Catch Pancreatic Cancer EarlyUniversity of Pennsylvania School of Medicine | April16th,2020 Penn study shows liquid biopsy may be viable option for both diagnosis and disease staging
NewsA Liquid Biopsy Test Can Identify Patients Who May Respond to Immune Checkpoint BlockadeAmerican Association for Cancer Research | September10th,2019 Further research, conducted across a broader range of tumor types, will be necessary to confirm the study results
NewsExperimental Noninvasive Tool Monitors Effectiveness of Stem Cell TransplantationUniversity of Maryland School of Medicine | May23rd,2019 Potential of transplanted stem cell secretions as a liquid biopsy
NewsNew Method Opens Unexplored Realms for Liquid BiopsiesMichigan Medicine - University of Michigan | May3rd,2019 A new approach reveals thousands of previously inaccessible RNA fragments in blood plasma that might serve as disease- and organ-specific biomarkers
Q&ABoosting the Clinical Utility of Liquid BiopsyMasha G. Savelieff, PhD | March31st,2019 A conversation with Maximilian Diehn, MD, PhD, associate professor of radiation oncology at Stanford University